NCT05934812View on ClinicalTrials.gov

Intranasal Oxytocin in Youth With Autism

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

November 4, 2025

Study Completion Date

November 4, 2025

Conditions
Autism Spectrum Disorder
Interventions
DRUG

Oxytocin nasal spray

24IU oxytocin liquid delivered with a pump-actuated nasal spray device, administered twice-daily

DRUG

Placebo

Placebo liquid nasal spray administered twice-daily

Trial Locations (1)

N-0424

Ullevål Hospital, Oslo

All Listed Sponsors
collaborator

University of Oslo

OTHER

lead

Oslo University Hospital

OTHER

NCT05934812 - Intranasal Oxytocin in Youth With Autism | Biotech Hunter | Biotech Hunter